United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 27, 2026 · Filed Jul 27, 2026

On Jul 27, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$530.42 for US$5.04M under a trading plan, leaving 324,443 shares. Filed Jul 27, 2026 (Form 4).

Sold
9,500 shares
Price
US$530.42 average (US$525.81 to US$535.04)
Value
US$5.04M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 27, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 27, 2026Common StockSale680US$525.81333,263Indirect
Jul 27, 2026Common StockSale890US$527.14332,373Indirect
Jul 27, 2026Common StockSale650US$528.51331,723Indirect
Jul 27, 2026Common StockSale1,797US$529.75329,926Indirect
Jul 27, 2026Common StockSale1,121US$530.49328,805Indirect
Jul 27, 2026Common StockSale1,836US$531.65326,969Indirect
Jul 27, 2026Common StockSale1,529US$532.38325,440Indirect
Jul 27, 2026Common StockSale957US$533.53324,483Indirect
Jul 27, 2026Common StockSale40US$535.04324,443Indirect

Source

View original at SEC

Related